{"id":"https://openalex.org/W2429937745","doi":null,"title":"Pharmacokinetics of prenylamine racemate and enantiomers in man.","display_name":"Pharmacokinetics of prenylamine racemate and enantiomers in man.","publication_year":1990,"publication_date":"1990-06-01","ids":{"openalex":"https://openalex.org/W2429937745","mag":"2429937745","pmid":"https://pubmed.ncbi.nlm.nih.gov/2397000"},"language":"en","primary_location":{"id":"pmid:2397000","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2397000","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025810246","display_name":"Paar Wd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799391451","display_name":"University Hospital Bonn","ror":"https://ror.org/01xnwqx93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799391451"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W D Paar","raw_affiliation_strings":["Medizinische Universit\u00e4tsklinik Bonn, Fed. Rep. of Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Universit\u00e4tsklinik Bonn, Fed. Rep. of Germany","institution_ids":["https://openalex.org/I2799391451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031295673","display_name":"D. Brockmeier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Brockmeier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080222165","display_name":"M Hirzebruch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Hirzebruch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035107644","display_name":"E K Schmidt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E K Schmidt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066662715","display_name":"G. von Unruh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G E von Unruh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037565461","display_name":"H. J. Dengler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H J Dengler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"40","issue":"6","first_page":"657","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prenylamine","display_name":"prenylamine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8050000071525574},{"id":"https://openalex.org/keywords/stereoselective-metabolism","display_name":"stereoselective metabolism","score":0.8859999775886536},{"id":"https://openalex.org/keywords/relative-bioavailability","display_name":"relative bioavailability","score":0.7200000286102295},{"id":"https://openalex.org/keywords/absolute-bioavailability","display_name":"absolute bioavailability","score":0.9010000228881836},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9150000214576721},{"id":"https://openalex.org/keywords/clearance","display_name":"clearance","score":0.4959999918937683},{"id":"https://openalex.org/keywords/mean-residence-time","display_name":"mean residence time","score":0.8579999804496765},{"id":"https://openalex.org/keywords/segontin","display_name":"Segontin","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8858654499053955},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.763034462928772},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7621427178382874},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.7402940988540649},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6585086584091187},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.538128137588501},{"id":"https://openalex.org/C181647583","wikidata":"https://www.wikidata.org/wiki/Q903429","display_name":"Stereoselectivity","level":3,"score":0.5065096616744995},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.40121620893478394},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15907269716262817},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.15877529978752136},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.10998532176017761},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007202","descriptor_name":"Indicators and Reagents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011299","descriptor_name":"Prenylamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2397000","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2397000","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"},{"id":"mag:2429937745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2397000","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1982908290","https://openalex.org/W1971058600","https://openalex.org/W2418225740","https://openalex.org/W2433894718","https://openalex.org/W1990909436","https://openalex.org/W2067508214","https://openalex.org/W2099337356","https://openalex.org/W2004223135","https://openalex.org/W2127280160","https://openalex.org/W2080103183"],"abstract_inverted_index":{"Pharmacokinetics":[0],"of":[1,48,63,92,109,127,135,159,164,166],"racemic":[2,49,86],"prenylamine":[3,50,64],"were":[4,12,20,138],"investigated":[5,139],"in":[6,72,103,124,140],"6":[7],"healthy":[8,74,142],"volunteers.":[9,75,143],"Plasma":[10],"levels":[11],"determined":[13,71],"by":[14,23],"gas":[15],"chromatography/mass":[16],"spectrometry.":[17],"Concentration-time":[18],"profiles":[19],"analyzed":[21],"both":[22],"compartment-dependent":[24],"and":[25,83],"compartment-independent":[26],"pharmacokinetic":[27],"models.":[28],"Terminal":[29],"elimination":[30],"half-life":[31],"was":[32,42,51,67,120,145,162],"14.1":[33],"h":[34,56],"(SD:":[35,57,69],"6.9":[36],"h).":[37,59],"The":[38,60,76,117,157],"apparent":[39],"total":[40],"clearance":[41],"5.8":[43],"l/min.":[44],"Mean":[45],"residence":[46],"time":[47],"found":[52],"to":[53,99,122],"be":[54,123],"14.7":[55],"3.8":[58],"relative":[61],"bioavailability":[62,119],"(Segontin":[65],"100)":[66],"82.2%":[68],"9.9%)":[70],"six":[73],"volunteers":[77],"received":[78],"simultaneously":[79],"the":[80,93,125,133,136,160,167],"film":[81],"tablet":[82],"100":[84],"mg":[85],"dideuteroprenylamine":[87],"as":[88],"an":[89],"aqueous":[90],"solution":[91],"lactate.":[94],"This":[95],"procedure":[96],"is":[97],"known":[98],"exclude":[100],"intraindividual":[101],"changes":[102],"absorption,":[104],"first-pass":[105],"metabolism":[106],"or":[107],"volume":[108],"distribution":[110],"that":[111,165],"might":[112],"occur":[113],"on":[114],"sequential":[115],"administration.":[116],"absolute":[118],"estimated":[121],"order":[126],"15%.":[128],"In":[129],"a":[130,154],"pilot":[131],"study":[132],"pharmacokinetics":[134],"enantiomers":[137],"2":[141],"S-(+)-prenylamine":[144],"eliminated":[146],"considerably":[147],"faster":[148],"from":[149],"plasma":[150],"than":[151],"R-(-)-prenylamine":[152],"suggesting":[153],"stereoselective":[155],"metabolism.":[156],"AUC":[158],"(+)-enantiomer":[161],"20%":[163],"R-(-)-prenylamine.":[168]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}